Abstract
Gastrin-releasing peptide (GRP), a bombesin-like peptide, is an autocrine or paracrine growth factor that can stimulate the growth of various cancer cells, making it an ideal target antigen to develop vaccines against cancer. In this study, we developed a novel DNA vaccine that encodes six tandem repeats of B-cell epitope GRP(18-27) (GRP6) flanked by HSP65 as carrier and four tandem repeats of mycobacterial HSP70(407-426) (M4) as helper T-cell epitopes for enhancement of immunogenicity. When intramuscularly immunized to mice, this anti-GRP DNA vaccine-induced GRP-specific antibody (Ab) responses that were at least 10-fold higher in magnitude compared with HSP65-GRP6 protein vaccine. Both prophylactic and therapeutic antitumor immunities induced by vaccination significantly suppressed the growth of GRP-dependent prostate carcinoma RM-1 in vivo and prolonged the survival of tumor-inoculated mice. Out results also showed that the immune sera with high titer of GRP-specific Abs effectively inhibited the growth of tumor in mice and dose dependently inhibited proliferation of cultured RM-1 cells in vitro, suggesting that the GRP neutralizing Ab is responsible for the protective and therapeutic antitumor activity of vaccination. These...Continue Reading
References
Jan 22, 1986·Journal of Immunological Methods·G R PullenC S Hosking
Sep 1, 1994·Protein Science : a Publication of the Protein Society·D I PapacK B Tomer
Apr 7, 1995·The Journal of Biological Chemistry·G S KroogJ F Battey
Sep 1, 1993·Clinical and Experimental Immunology·R PerrautJ Gysin
Jul 29, 1997·International Journal of Cancer. Journal International Du Cancer·A G AprikianS Chevalier
Jun 1, 1997·Molecular Immunology·M KjerrulfN Lycke
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M MiyazakiR Z Cai
Aug 14, 1999·The Journal of Biological Chemistry·M R HellmichC M Townsend
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M DupuisD M McDonald
Dec 6, 2000·European Journal of Pharmacology·T W MoodyJ Leyton
Nov 1, 2002·Regulatory Peptides·Dongmei XiaoH Christian Weber
Aug 12, 2003·European Journal of Pharmacology·Terry W MoodyRobert T Jensen
Sep 26, 2003·Cancer·Karoly SzepeshaziGabor Halmos
Mar 16, 2004·The Journal of Biological Chemistry·Terry W MoodyRobert T Jensen
Mar 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yufei WangThomas Lehner
Feb 9, 2006·Vaccine·Sonali NimalMark S Thomas
Feb 24, 2006·Biochimica Et Biophysica Acta·Oneel PatelGraham S Baldwin
May 27, 2006·Biochemical and Biophysical Research Communications·Zhang YankaiWu Jie
Jan 17, 2007·Vaccine·Liang JinJingjing Liu
May 17, 2007·Current Cancer Drug Targets·G González, A Lage
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Liang JinJingjing Liu
Mar 4, 2008·Endocrine-related Cancer·Wu GuojunCao Rongyue
Jun 13, 2008·Acta Tropica·Setty Balakrishnan AnandPerumal Kaliraj
Jul 21, 2009·Vaccine·Yong LuJingjing Liu
Citations
Oct 22, 2011·International Immunopharmacology·Chiyu GeJingjing Liu
Apr 24, 2016·International Journal of Pharmaceutics·Zhaoyan ZengLi Zong
May 26, 2016·Cancer Immunology, Immunotherapy : CII·Thomas V GuyBarbara Fazekas de St. Groth
Sep 17, 2019·The Veterinary Quarterly·Saurabh GuptaKuldeep Dhama
Nov 3, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Ishita D Majumdar, Horst C Weber